The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysisResearch in context

• Main Authors: Xingxian Luo (Author), Xin Du (Author), Lin Huang (Author), Qixiang Guo (Author), Ruijie Tan (Author), Yue Zhou (Author), Zhuangqi Li (Author), Xuecai Xue (Author), Taifeng Li (Author), Kaidi Le (Author), Feng Qian (Author), Shein-Chung Chow (Author), Yue Yang (Author)
• Format: Book
• Published: Elsevier, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Affordability to novel anticancer drugs has become a major health issue in China. It is encouraging to note that China initiated its drug regulatory reform and national price negotiation policies since 2015. As a growing number of domestic within-class targeted anticancer drugs...